Clincosm LogoSign in Get a demo

Bladder Cancer

Showing NaN - NaN of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer Trial in Worldwide (TAR-200, Cetrelimab, BCG Vesiculture)

Not yet recruiting
  • Bladder Cancer
  • Scottsdale, Arizona
  • +241 more
Feb 9, 2023

Melanoma, NSCLC, Bladder Cancer Trial in Worldwide (Autogene cevumeran, Atezolizumab)

Active, not recruiting
  • Melanoma
  • +7 more
  • Scottsdale, Arizona
  • +36 more
Dec 22, 2022

Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder Trial in United States (UGN-301, UGN-201)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • +5 more
  • Little Rock, Arkansas
  • +7 more
Dec 19, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Bladder Cancer Trial in Worldwide (Atezolizumab)

Active, not recruiting
Has Results
  • Bladder Cancer
  • Birmingham, Alabama
  • +76 more
Dec 6, 2022

Intravesical Therapy and Surgery as Treatment Options for

Recruiting
  • Bladder Cancer
  • +2 more
    • Birmingham, Alabama
    • +37 more
    Nov 28, 2022

    Pancreatic Cancer, Small Bowel Cancer, Colorectal Cancer Trial in United States (Ulixertinib (BVD-523))

    Available
    • Pancreatic Cancer
    • +20 more
    • Ulixertinib (BVD-523)
    • Birmingham, Alabama
    • +25 more
    Nov 4, 2022

    Bladder Cancer Trial in United States (N-803 and BCG, N-803)

    Recruiting
    • Bladder Cancer
    • Anchorage, Alaska
    • +31 more
    Oct 26, 2022

    Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

    Recruiting
    • Solid Tumor
    • +11 more
    • TRK-950
    • +14 more
    • Scottsdale, Arizona
    • +13 more
    Oct 2, 2022

    Urothelial Carcinoma, Bladder Cancer Trial in United States (Placebo, Pembrolizumab)

    Completed
    Has Results
    • Urothelial Carcinoma
    • Bladder Cancer
    • Phoenix, Arizona
    • +27 more
    Sep 16, 2022

    Bladder Cancer Trial in Canada, United States (therapeutic conventional surgery, therapeutic standard lymphadenectomy,

    Active, not recruiting
    • Bladder Cancer
    • therapeutic conventional surgery
    • +2 more
    • Los Angeles, California
    • +34 more
    Jul 20, 2022

    Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102)

    Recruiting
    • Bladder Cancer
    • +2 more
    • Tucson, Arizona
    • +76 more
    Jul 13, 2022

    Bladder Cancer, Urothelial Carcinoma Trial in United States (OGX-427, Docetaxel)

    Completed
    Has Results
    • Bladder Cancer
    • Urothelial Carcinoma
    • Birmingham, Alabama
    • +34 more
    Jul 7, 2022

    Bladder Cancer Trial in United States (Nivolumab, Gemcitabine, Cisplatin)

    Active, not recruiting
    • Bladder Cancer
    • Duarte, California
    • +6 more
    Jul 7, 2022

    A Diagnostic for the Early Detection of Bladder Cancer

    Recruiting
    • Bladder Cancer
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Apr 29, 2022

      A Novel Multiplex ELISA Assay for Surveilling History of Bladder

      Active, not recruiting
      • Bladder Cancer
        • Los Angeles, California
        • +3 more
        Apr 5, 2022

        Ovarian Cancer, Hepatocellular Carcinoma, NSCLC Trial in Canada, United States (DPX-Survivac, Cyclophosphamide, Pembrolizumab)

        Active, not recruiting
        • Ovarian Cancer
        • +4 more
        • DPX-Survivac
        • +2 more
        • Tucson, Arizona
        • +22 more
        Mar 28, 2022

        A Novel Multiplex ELISA Assay for Evaluating Microscopic

        Recruiting
        • Bladder Cancer
          • Los Angeles, California
          • +1 more
          Mar 7, 2022

          A Novel Multiplex ELISA Assay for Evaluating Gross Hematuria for

          Recruiting
          • Bladder Cancer
            • Los Angeles, California
            • +3 more
            Mar 7, 2022

            Predicting BCG Response

            Recruiting
            • Bladder Cancer
              • Los Angeles, California
                Cedars-Sinai Medical Center
              Mar 7, 2022

              Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)

              Active, not recruiting
              • Urothelial Carcinoma
              • +3 more
              • Biospecimen Collection
              • Los Angeles, California
              • +7 more
              Feb 14, 2022

              Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)

              Completed
              • Prostate Cancer
              • +6 more
              • MGA271
              • Los Angeles, California
              • +11 more
              Feb 4, 2022

              Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)

              Terminated
              • Mesothelioma
              • +12 more
              • MGD009
              • Los Angeles, California
              • +19 more
              Feb 4, 2022

              Bladder Cancer Cell Transitional, Non-Muscle Invasive Bladder Cancer, Bladder Cancer Trial in United States (TSD-001)

              Completed
              • Bladder Cancer Cell Transitional
              • +9 more
              • Tucson, Arizona
              • +4 more
              Jan 18, 2022

              Bladder Cancer, Urinary Bladder Tumor, Urologic Tumors Trial in Los Angeles, Boston (Fiducial marker placement, Multiparametric

              Recruiting
              • Bladder Cancer
              • +4 more
              • Fiducial marker placement
              • Multiparametric MRI (mpMRI)
              • Los Angeles, California
              • +1 more
              Jan 7, 2022